TB Care

Overview

What is Tuberculosis?

Tuberculosis is a bacterial infection caused by Mycobacterium tuberculosis and is often shortened to TB. It can affect other body parts, but it most commonly attacks the lungs, where it is known as pulmonary tuberculosis. The infection spreads from person to person when tiny droplets are released into the air when someone with active TB coughs, sneezes or speaks.

Not everyone infected with the bacteria becomes unwell. Many people have what is called latent tuberculosis. This is when the bacteria remain dormant in the body and cause no symptoms and this form is not contagious. Latent infection can, however, progress to active disease when the immune system cannot keep the bacteria under control.

It has been around for centuries, but tuberculosis still remains a significant global health concern. Tuberculosis treatment, when managed correctly by experienced specialists, is highly effective.

Types of Tuberculosis

There are several forms in which tuberculosis presents itself, each distinct. It is not a single disease. Each type requires a different approach to care.

Pulmonary Tuberculosis

The most common type is pulmonary tuberculosis, which affects the lungs directly. A persistent cough, chest pain and coughing up blood are typical symptoms. This form is also the most contagious because the bacteria can be spread through respiratory droplets.

Latent Tuberculosis

Another form is latent tuberculosis, which occurs when a person carries the bacteria but has no symptoms and cannot pass the infection on to others. When examined, chest X-rays appear normal, and sputum tests come back negative. Particularly if the immune system becomes weakened, latent TB carries the risk of becoming active later without treatment.

Extrapulmonary Tuberculosis

Extrapulmonary tuberculosis is another type that occurs when the infection spreads beyond the lungs to other parts of the body. This can affect many body systems such as the lymph nodes, bones and joints, the digestive system, the lining of the brain or the kidneys. A rare but serious form is miliary tuberculosis. This happens when the bacteria spread through the bloodstream to multiple organs simultaneously. Another category where the bacteria do not respond to standard first-line medications is referred to as drug-resistant tuberculosis. This includes multidrug-resistant TB, and treatment is more complex and prolonged.

Sometimes dismissed for a stubborn cold, a cough that lingers for three weeks or longer should not be taken lightly. Any patient experiencing this needs a proper medical evaluation. This is particularly important when it's accompanied by other symptoms. Classic signs of active tuberculosis are unexplained weight loss, night sweats that soak through bedding, fever and extreme fatigue that does not improve with rest at all.

Coughing up blood, even in small amounts, warrants an immediate medical appointment. Another concerning sign is chest pain that worsens with breathing or coughing. If they have been in close contact with someone diagnosed with active tuberculosis, patients should seek screening immediately. This is important even without symptoms. Those with weakened immune systems, including individuals with HIV, diabetes or those taking immunosuppressive medications, should be particularly vigilant as they face a higher risk. Specialist paediatricians are trained to recognise the often subtler signs of TB in younger patients. This helps families seeking care at a tuberculosis children's hospital.

Diagnosis accuracy and type are the most effective steps for tuberculosis treatment. Symptoms, medical history and any potential exposure to tuberculosis are all thoroughly discussed. A physical examination, including listening carefully to the lungs, provides additional clues.

Typically, a chest X-ray is the first step with imaging. Certain patterns seen on X-ray raise suspicion of tuberculosis. These are cavities or infiltrates in the upper lobes. Imaging alone, however, cannot confirm the diagnosis. Sputum microscopy, which examines mucus coughed up from the lungs under a microscope to look for bacteria, is highly effective. A more sensitive test, sputum culture, allows the bacteria to grow in a laboratory setting to confirm the diagnosis and test for drug resistance. This takes several weeks, however provides the essential information necessary for guiding treatment. Molecular tests, like GeneXpert, deliver results much faster, often within hours and can also detect drug resistance patterns. A bronchoscopy or needle biopsy of affected tissue may be required for patients who cannot produce sputum. This is also done when extrapulmonary TB is suspected.

  • Pulmonary tuberculosis (active and latent)
  • Extrapulmonary tuberculosis affecting lymph nodes, bones or abdomen
  • Tuberculous meningitis
  • Miliary tuberculosis
  • Multidrug-resistant tuberculosis
  • Drug-sensitive tuberculosis requiring standard therapy
  • Tuberculosis in children and adolescents
  • Post-tuberculosis lung disease and bronchiectasis
  • Tuberculosis in immunocompromised patients
  • Latent TB infection requiring preventive therapy

Effective tuberculosis treatment is built around curing the infection while preventing spread to others, at NMC. To understand the type of TB, drug sensitivity results and individual health status of each patient, all our assessments are thorough. We build a personalised plan from there, tailored to the specific needs of every case.

Standard treatment involves a combination of four antibiotics taken over a course of six months for drug-sensitive pulmonary tuberculosis. The first two months typically include four medications, followed by four months with two medications. Adherence is absolutely critical as missing doses can lead to treatment failure or the development of drug resistance. Directly Observed Therapy is often used, which is when a healthcare professional watches the patient take each dose, which ensures compliance and improves outcomes.

Treatment is more complex, lasting anywhere from nine to twenty months, for drug-resistant tuberculosis. Regimens use second-line medications in this instance. Some are given as injections or daily pills with closer monitoring for side effects. To eliminate the bacteria before it can cause active disease, many patients with latent tuberculosis may be offered preventive monotherapy.

Patients can benefit from isolation at a tuberculosis Dubai hospital within the NMC network to prevent spread, comprehensive contact tracing and ongoing support throughout the treatment journey. The service, fully comprehensive, includes nutritional support, counselling and management of medication side effects. Younger patients receive age-appropriate dosing from paediatric specialists, ensuring family-centred care. This is especially important for families seeking a tuberculosis children's hospital environment.

The expertise of our team of consultant pulmonologists is advanced and varied, covering tuberculosis and other mycobacterial infections. These specialists have managed TB across a wide range of patient populations. From healthy adults to children, the elderly and those with complex underlying conditions, Infectious disease physicians, respiratory nurses, radiologists and microbiologists support them. They all play a crucial role in ensuring accurate diagnosis and effective treatment.

Our consultants understand that a diagnosis of tuberculosis can bring fears about contagion, stigma and the length of treatment. They are attentive and operate with a human-based approach. They explain each step and involve patients in all decisions. Across the UAE, NMC offers accessible, high-quality care. We are here to support all those seeking expert tuberculosis treatment in Dubai, Abu Dhabi or anywhere across the NMC network.

FAQs

Find the Answer to Your Medical Questions

Frequently Asked Questions

Six months is the typical treatment time for standard drug-sensitive TB. The first two months use four medications. This is followed by four months using two medications. Drug-resistant TB requires longer treatment. This can sometimes be nine to twenty months, depending on the resistance pattern.
The first few weeks of treatment are critical because patients with active pulmonary TB are contagious. Until sputum tests show no bacteria, isolation is recommended, which usually takes two to four weeks. Normal activities can resume while continuing the full course of medication, and also once a doctor confirms you are no longer contagious.
Missing doses is serious as it can allow the bacteria to become resistant to the medication. This makes treatment much harder. Medication must be taken exactly as prescribed, and if a dose is missed, you must contact your doctor immediately. Directly Observed Therapy is often recommended for this reason.
When the full course of treatment is completed properly, it is uncommon, but relapse is possible. Patients who finish their prescribed regimen have a very low risk of recurrence. But doctors need to rule out relapse or post-TB lung damage, so those with persistent symptoms after treatment should return for re-evaluation.
Location

NMC Footprints

0 Results found

Loading......